Cargando…

Sulforaphane protects human umbilical vein endothelial cells from oxidative stress via the miR-34a/SIRT1 axis by upregulating nuclear factor erythroid-2-related factor 2

Oxidative stress-induced vascular endothelial cell dysfunction serves an essential role in the initiation and development of atherosclerosis. Sulforaphane (SFN), a naturally occurring antioxidant, has previously demonstrated to exert protective effects on the endothelium against oxidative stress. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tao, Pang, Qi, Liu, Yongbin, Bai, Ming, Peng, Yu, Zhang, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812584/
https://www.ncbi.nlm.nih.gov/pubmed/33488795
http://dx.doi.org/10.3892/etm.2021.9617
_version_ 1783637700817977344
author Li, Tao
Pang, Qi
Liu, Yongbin
Bai, Ming
Peng, Yu
Zhang, Zheng
author_facet Li, Tao
Pang, Qi
Liu, Yongbin
Bai, Ming
Peng, Yu
Zhang, Zheng
author_sort Li, Tao
collection PubMed
description Oxidative stress-induced vascular endothelial cell dysfunction serves an essential role in the initiation and development of atherosclerosis. Sulforaphane (SFN), a naturally occurring antioxidant, has previously demonstrated to exert protective effects on the endothelium against oxidative stress. However, further studies are required to determine its underlying molecular mechanism prior to clinical application. Accumulating evidence suggests that alterations in the microRNA (miRNA/miR)-34a/sirtuin-1 (SIRT1) axis occur with oxidative stress. Therefore, the present study aimed to investigate if SFN exerts a protective role against oxidative stress in vascular endothelial cells through regulation of the miR-34a/SIRT1 axis. Human umbilical vein endothelial cells (HUVECs) were treated with H(2)O(2) in the presence or absence of SFN pretreatment. Cell viability and apoptosis were analyzed using CellTiter-Blue and flow cytometry, respectively. Reverse transcription-quantitative PCR and western blot analyses were performed to determine changes in the expression levels of miR-34a and SIRT1. The expression levels of miR-34a and SIRT1 were artificially regulated following transfection with miR-34a mimic and inhibitor or SIRT1expression plasmid and small interfering RNA, respectively. Subsequently, the effect of the expression changes of miR-34 and SIRT1 on oxidative stress-induced cell injury was investigated. Dual-luciferase reporter assay was used to confirm the targeted binding of miR-34a to SIRT1. SFN was found to ameliorate cellular damage caused by H(2)O(2) and inhibited intracellular reactive oxygen species production. In addition, miR-34a upregulation was accompanied with reduced SIRT1 expression in HUVECs, following H(2)O(2) treatment. miR-34a was revealed to directly target SIRT1 by binding to its 3'-untranslated region. Down-regulation of miR-34a and up-regulation of SIRT1 increased the survival of HUVECs under oxidative stress. Taken together, the results of the present study suggest that SFN may protect HUVECs from oxidative stress by inducing changes in the miR-34a/SIRT1 axis via upregulation of nuclear factor erythroid-2-related factor 2 expression.
format Online
Article
Text
id pubmed-7812584
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-78125842021-01-22 Sulforaphane protects human umbilical vein endothelial cells from oxidative stress via the miR-34a/SIRT1 axis by upregulating nuclear factor erythroid-2-related factor 2 Li, Tao Pang, Qi Liu, Yongbin Bai, Ming Peng, Yu Zhang, Zheng Exp Ther Med Articles Oxidative stress-induced vascular endothelial cell dysfunction serves an essential role in the initiation and development of atherosclerosis. Sulforaphane (SFN), a naturally occurring antioxidant, has previously demonstrated to exert protective effects on the endothelium against oxidative stress. However, further studies are required to determine its underlying molecular mechanism prior to clinical application. Accumulating evidence suggests that alterations in the microRNA (miRNA/miR)-34a/sirtuin-1 (SIRT1) axis occur with oxidative stress. Therefore, the present study aimed to investigate if SFN exerts a protective role against oxidative stress in vascular endothelial cells through regulation of the miR-34a/SIRT1 axis. Human umbilical vein endothelial cells (HUVECs) were treated with H(2)O(2) in the presence or absence of SFN pretreatment. Cell viability and apoptosis were analyzed using CellTiter-Blue and flow cytometry, respectively. Reverse transcription-quantitative PCR and western blot analyses were performed to determine changes in the expression levels of miR-34a and SIRT1. The expression levels of miR-34a and SIRT1 were artificially regulated following transfection with miR-34a mimic and inhibitor or SIRT1expression plasmid and small interfering RNA, respectively. Subsequently, the effect of the expression changes of miR-34 and SIRT1 on oxidative stress-induced cell injury was investigated. Dual-luciferase reporter assay was used to confirm the targeted binding of miR-34a to SIRT1. SFN was found to ameliorate cellular damage caused by H(2)O(2) and inhibited intracellular reactive oxygen species production. In addition, miR-34a upregulation was accompanied with reduced SIRT1 expression in HUVECs, following H(2)O(2) treatment. miR-34a was revealed to directly target SIRT1 by binding to its 3'-untranslated region. Down-regulation of miR-34a and up-regulation of SIRT1 increased the survival of HUVECs under oxidative stress. Taken together, the results of the present study suggest that SFN may protect HUVECs from oxidative stress by inducing changes in the miR-34a/SIRT1 axis via upregulation of nuclear factor erythroid-2-related factor 2 expression. D.A. Spandidos 2021-03 2021-01-07 /pmc/articles/PMC7812584/ /pubmed/33488795 http://dx.doi.org/10.3892/etm.2021.9617 Text en Copyright: © Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Li, Tao
Pang, Qi
Liu, Yongbin
Bai, Ming
Peng, Yu
Zhang, Zheng
Sulforaphane protects human umbilical vein endothelial cells from oxidative stress via the miR-34a/SIRT1 axis by upregulating nuclear factor erythroid-2-related factor 2
title Sulforaphane protects human umbilical vein endothelial cells from oxidative stress via the miR-34a/SIRT1 axis by upregulating nuclear factor erythroid-2-related factor 2
title_full Sulforaphane protects human umbilical vein endothelial cells from oxidative stress via the miR-34a/SIRT1 axis by upregulating nuclear factor erythroid-2-related factor 2
title_fullStr Sulforaphane protects human umbilical vein endothelial cells from oxidative stress via the miR-34a/SIRT1 axis by upregulating nuclear factor erythroid-2-related factor 2
title_full_unstemmed Sulforaphane protects human umbilical vein endothelial cells from oxidative stress via the miR-34a/SIRT1 axis by upregulating nuclear factor erythroid-2-related factor 2
title_short Sulforaphane protects human umbilical vein endothelial cells from oxidative stress via the miR-34a/SIRT1 axis by upregulating nuclear factor erythroid-2-related factor 2
title_sort sulforaphane protects human umbilical vein endothelial cells from oxidative stress via the mir-34a/sirt1 axis by upregulating nuclear factor erythroid-2-related factor 2
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812584/
https://www.ncbi.nlm.nih.gov/pubmed/33488795
http://dx.doi.org/10.3892/etm.2021.9617
work_keys_str_mv AT litao sulforaphaneprotectshumanumbilicalveinendothelialcellsfromoxidativestressviathemir34asirt1axisbyupregulatingnuclearfactorerythroid2relatedfactor2
AT pangqi sulforaphaneprotectshumanumbilicalveinendothelialcellsfromoxidativestressviathemir34asirt1axisbyupregulatingnuclearfactorerythroid2relatedfactor2
AT liuyongbin sulforaphaneprotectshumanumbilicalveinendothelialcellsfromoxidativestressviathemir34asirt1axisbyupregulatingnuclearfactorerythroid2relatedfactor2
AT baiming sulforaphaneprotectshumanumbilicalveinendothelialcellsfromoxidativestressviathemir34asirt1axisbyupregulatingnuclearfactorerythroid2relatedfactor2
AT pengyu sulforaphaneprotectshumanumbilicalveinendothelialcellsfromoxidativestressviathemir34asirt1axisbyupregulatingnuclearfactorerythroid2relatedfactor2
AT zhangzheng sulforaphaneprotectshumanumbilicalveinendothelialcellsfromoxidativestressviathemir34asirt1axisbyupregulatingnuclearfactorerythroid2relatedfactor2